Clinical Trial Update: Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial investigating re-dosing with otelixizumab in adults with newly diagnosed Type 1 diabetes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Otelixizumab (otelixizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2017-06-16